Is Angioplasty at Centers Without Surgical Backup Safe?

Performing coronary angioplasties at hospitals without surgical backup seems to be safe for a wide variety of patients, from those presenting ST-segment elevation myocardial infarction to those undergoing elective procedures.

 

This work responds to a long-running debate over whether centers without on-site surgery capabilities in case of complications can be considered as referral centers for primary angioplasty (emergency angioplasty) only, or can also perform scheduled procedures.

 

Centers without surgical capabilities have argued in their defense that the performance of scheduled procedures ensured that proper proficiency be maintained for emergency cases.

 

This is the first real-world study showing that it is probably safe to perform coronary angioplasties at centers without surgical backup.

 

The study included data from the Nationwide Inpatient Sample of almost 7 million patients who received an angioplasty in the United States between 2003 and 2012. Overall, 5.7% of the procedures were performed at centers without surgical backup, and the proportion increased with time (1.8% in 2003 vs. 12.7% in 2013; p < 0.001).

 

Hospitals lacking surgical backup performed primary angioplasties more frequently than larger centers with surgical capabilities (34% vs. 20%; p < 0.001).

  • The rate for non-ST-segment elevation acute coronary syndrome was similar (41.8% vs. 42.6%).
  • Scheduled angioplasties were more frequent at centers with surgical capabilities (24.1% vs. 38.2%).
  • Mortality was lower at centers with on-site surgery (1.4% vs. 1.9%; odds ratio [OR] 0.74), but the difference disappeared after researchers adjusted for procedural indication (elective or emergency procedure).

 

The annual angioplasty volume was less than 200 annual cases in two-thirds of the centers without surgical backup.

 

Original title: Outcomes and Temporal Trends of Inpatient Percutaneous Coronary Intervention at Centers With and Without On-site Cardiac Surgery in the United States.

Presenter:  Goel K.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Left or Right Transradial Approach? Comparing Radiation Exposure in Coronary Procedures

Radiation exposure during percutaneous procedures is a problem both for patients and operators. The transradial is currently the preferred approach, vs. femoral; however, whether...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....